Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Oncogene|September 30, 2014
Posttranslational modifications of RUNX1 as potential anticancer targetsS Goyama, G Huang, M Kurokawa, et al.
Oncogene|September 22, 2009
Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cellsM Shimabe, S Goyama, N Watanabe-Okochi, et al.
Leukemia|March 14, 2008
AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1M Takeshita, M Ichikawa, E Nitta, et al.
Leukemia|September 25, 2009
EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalizationS Goyama, E Nitta, T Yoshino, et al.
Oncogene|November 8, 2016
Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemiaS Goyama, M Shrestha, J Schibler, et al.
Oncogene|April 22, 2014
Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemiaT Sato, S Goyama, K Kataoka, et al.
Leukemia & Lymphoma|January 21, 2003
Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantationS Goyama, Y Kanda, Y Nannya, et al.
Leukemia|July 20, 2017
High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesisK C Kawabata, Y Hayashi, D Inoue, et al.
Bone Marrow Transplantation|December 4, 2003
Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantationY Asano, Y Kanda, N Ogawa, et al.
Leukemia|October 10, 2015
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETOS Goyama, J Schibler, A Gasilina, et al.
Pageof 1